While AI is reshaping frontline healthcare at pace—spotting cancers, triaging patients, and summarising records—its uptake in ...

Novartis has unveiled plans to invest $23bn into its US-based infrastructure over the next five years, allowing it to produce ...

Johnson & Johnson (J&J) has announced that an injectable version of Rybrevant (amivantamab) has been approved by the European ...

Bayer’s Vitrakvi (larotrectinib) has been granted traditional approval by the US Food and Drug Administration (FDA) to treat ...

Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), ...